Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
about
The promise of immunotherapy in head and neck squamous cell carcinomaTumor antigen-specific monoclonal antibodies and induction of T-cell immunityAnti-α-enolase is a prognostic marker in postoperative lung cancer patientsRelationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas.SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsImmune suppression in head and neck cancers: a reviewImmune biomarkers of anti-EGFR monoclonal antibody therapyAssociation between LMP2 and LMP7 gene polymorphisms and the risk of gastric cancer: A case-control studySTAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.Promising systemic immunotherapies in head and neck squamous cell carcinoma.Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells.Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC.Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer.Immune alterations and immunotherapy prospects in head and neck cancer.Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer.Immunotherapy for head and neck cancer: the future of treatment?Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.Clinical impact of HLA class I expression in rectal cancer.Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towaTargeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.Tumors with a more complex genome have a higher frequency of HLA class I total loss: a unifying pan-cancer hypothesisImmune suppression and evasion in patients with head and neck cancerImmune Checkpoint Inhibition in Head and Neck Cancer
P2860
Q26744433-62DA5532-A275-46D5-BF0B-24192BC38E6FQ27009908-60F855CD-594A-4125-9C25-D6BAFB871793Q28601320-9DD1DA60-9312-482E-9B9F-D030B7620B0AQ30425423-0F78B15C-0D54-40A0-B89D-C17984756D50Q30536340-B5A22E28-017E-41B1-A8FE-D54613CFD805Q34194706-A392A497-6DD4-49D7-A2C5-9477F182D3ACQ34477550-8300CA68-9A90-4722-9F76-D9A3A1DB3866Q34700675-EBEEDB65-86AD-48A1-B8F4-EBE2D92474B7Q34723594-FE8D3CFD-4329-4182-BE11-9B02D102C924Q35803694-3D9A11AB-E81C-4D02-A7F6-038AE6DD3553Q35920773-541CDD6E-2AB5-4A3E-B704-F9A4CF06AA8FQ36759294-1A3F597D-BC4A-4DB5-8F36-D9649B4334AFQ36883848-86CA597C-4CD2-4072-B241-20770B8E2A9EQ37605030-8D829F58-779B-43B8-A4BE-B28A4CC16F94Q37675926-BA53DF54-7234-4121-9A57-ACA8695EDDFCQ37997734-3B44BCCF-0DDF-4553-AD3F-054E9AAE83B7Q38116067-365C0E75-5B36-4BE7-861A-69C8006E305FQ38162129-CC4DAEA4-10E3-42BD-8AC7-88571BF3488FQ38736238-F0024E44-169B-46F0-BB82-2B30C1EE8ABCQ39190801-D39869A1-CA4A-48B4-B1E6-4E36AECBA0B7Q39612090-48C53A9D-63A2-44A8-BDBA-52DA367D32A3Q40173498-9678FDAF-63F9-46E9-A119-C4B3E722D092Q42205916-5A939B19-6AE7-4352-B33E-6DF2FDF1AB67Q47350013-542C4D97-7CA0-4CDC-9C1C-8EC86547F7B9Q50058491-12699732-5BB5-49B6-BE87-CABD3ACBF41AQ50249146-F42583BF-DCAB-4410-9427-C8C22EEEDCEFQ50960953-8DC5F3EE-E1B2-43BD-8540-574EC60DADF0Q51063063-CB745164-CDB0-40D6-AA27-E6CC7329AFAEQ53265013-DB03780B-7A07-4411-975B-B947F12AB4F8Q58050251-A7E0FBB7-B425-4A6E-94D1-FC7E01C6879EQ58289735-63FA7B33-AB85-4D8D-9EBA-15BF882B34E8Q58694216-0B579FFE-A475-4917-A3A8-59CD0680A132
P2860
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@ast
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@en
type
label
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@ast
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@en
prefLabel
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@ast
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@en
P2093
P356
P1433
P1476
Human leukocyte antigen (HLA) ...... sms and clinical significance.
@en
P2093
Jennifer L Hunt
Robert L Ferris
Soldano Ferrone
P2888
P304
P356
10.1385/IR:33:2:113
P577
2005-01-01T00:00:00Z
P6179
1051360987